# Medication Acronym Analysis Report

**Date:** 2026-01-31
**Contexts Analyzed:** 172 high-priority medication acronym occurrences
**Acronyms Reviewed:** LDA, LDN, NAC, BH4, DHEA, ALA

---

## Executive Summary

✅ **ALL DEFINITIONS CORRECT**

All 172 medication acronym contexts use the correct definitions:
- **LDA** = Low-Dose Aripiprazole (NOT aspirin) ✓
- **LDN** = Low-Dose Naltrexone ✓
- **NAC** = N-Acetylcysteine ✓
- **BH4** = Tetrahydrobiopterin ✓
- **DHEA** = Dehydroepiandrosterone ✓
- **ALA** = Alpha-Lipoic Acid ✓

⚠️ **36 Missing Expansions Found**

36 contexts lack nearby expansion (within ±50 lines), requiring attention for first-use clarity.

---

## Detailed Breakdown by Acronym

### LDA (Low-Dose Aripiprazole)
- **Total occurrences:** 1
- **Correct:** 1 (100%)
- **Missing expansion:** 0
- **Errors:** 0

**Status:** ✅ Perfect - correctly expanded on first use.

---

### LDN (Low-Dose Naltrexone)
- **Total occurrences:** 75
- **Correct:** 59 (79%)
- **Missing expansion:** 16 (21%)
- **Errors:** 0

**Missing expansion locations:**
1. `appendix-i-c-case-analysis.tex:1066`
2. `appendix-i-c-case-analysis.tex:1193`
3. `appendix-i-personal-symptoms.tex:228`
4. `appendix-i-personal-symptoms.tex:1377`
5. `appendix-i-personal-symptoms.tex:2122`
6. `appendix-i-personal-symptoms.tex:2726`
7. `appendix-i-personal-symptoms.tex:2886`
8. `appendix-i-personal-symptoms.tex:2920`
9. `ch04-07-novel-framework.tex:528`
10. `ch04-07-novel-framework.tex:789`
11. `ch14i-clinical-brainstorm.tex:447`
12. `ch25-translational-findings.tex:626`
13. `ch25-translational-findings.tex:1544`
14. `ch25-translational-findings.tex:1553`
15. `ch25-translational-findings.tex:1554`
16. `ch25-translational-findings.tex:1565`

**Recommendation:** Add "Low-Dose Naltrexone (LDN)" expansion on first use in each section/chapter.

---

### NAC (N-Acetylcysteine)
- **Total occurrences:** 47
- **Correct:** 39 (83%)
- **Missing expansion:** 8 (17%)
- **Errors:** 0

**Missing expansion locations:**
1. `ch05-subgroups.tex:508`
2. `ch05-subgroups.tex:547`
3. `ch14-main.tex:48`
4. `ch14f-cpet-derived.tex:278`
5. `ch15-medications-systems.tex:837`
6. `ch25-translational-findings.tex:464`
7. `ch25-translational-findings.tex:605`
8. `ch25-translational-findings.tex:950`

**Recommendation:** Add "N-Acetylcysteine (NAC)" expansion on first use in each section/chapter.

---

### BH4 (Tetrahydrobiopterin)
- **Total occurrences:** 41
- **Correct:** 30 (73%)
- **Missing expansion:** 11 (27%)
- **Errors:** 0

**Missing expansion locations:**
1. `ch14-main.tex:26`
2. `ch14f-cpet-derived.tex:17`
3. `ch14f-cpet-derived.tex:43`
4. `ch14f-cpet-derived.tex:278`
5. `ch18-emerging-therapies.tex:923`
6. `ch25-translational-findings.tex:298`
7. `ch25-translational-findings.tex:326`
8. `ch25-translational-findings.tex:332`
9. `ch25-translational-findings.tex:464`
10. `ch25-translational-findings.tex:1200`
11. `ch25-translational-findings.tex:1706`

**Recommendation:** Add "Tetrahydrobiopterin (BH4)" expansion on first use in each section/chapter.

---

### DHEA (Dehydroepiandrosterone)
- **Total occurrences:** 3
- **Correct:** 2 (67%)
- **Missing expansion:** 1 (33%)
- **Errors:** 0

**Missing expansion locations:**
1. `ch14i-clinical-brainstorm.tex:324`

**Recommendation:** Add "Dehydroepiandrosterone (DHEA)" expansion on first use in section.

---

### ALA (Alpha-Lipoic Acid)
- **Total occurrences:** 5
- **Correct:** 5 (100%)
- **Missing expansion:** 0
- **Errors:** 0

**Status:** ✅ Perfect - all uses properly expanded.

---

## Critical Findings

### ✅ No Definition Errors
The most critical concern (LDA = aspirin confusion) was **NOT FOUND**. All medication acronyms use correct definitions throughout the document.

### ⚠️ Expansion Issues
36 contexts lack nearby expansion. These are primarily:
- **Repeated uses** in long chapters where first use has expansion elsewhere
- **Section-internal references** where acronym appears mid-section
- **Cross-references** where context assumes prior knowledge

**Not errors, but sub-optimal for readability.**

---

## Recommendations

### Priority 1: Verify Critical Definition (COMPLETE)
✅ LDA = Low-Dose Aripiprazole confirmed throughout (not aspirin)

### Priority 2: Add Expansions for First Use in Sections
For the 36 flagged locations, consider:

1. **Per-chapter first use:** Expand acronym on first occurrence in each chapter
2. **Section headers:** Add expansion in section/subsection introducing the medication
3. **Context clues:** Ensure surrounding text provides enough context for readers

### Priority 3: Review Dense Chapters
Chapters with many missing expansions:
- `ch25-translational-findings.tex` (11 missing)
- `appendix-i-personal-symptoms.tex` (7 missing)
- `ch14f-cpet-derived.tex` (4 missing)

**Consider:** Adding a "Medications Referenced" box at chapter start or in margin notes.

---

## Analysis Methodology

### Verification Approach
1. **Definition correctness:** Check for verification keywords (e.g., "naltrexone" near "LDN") or contradictory terms (e.g., "aspirin" with "LDA")
2. **Expansion presence:** Search ±50 lines for full medication name
3. **Context assessment:** Determine if expansion is required based on usage type (body text vs. abbreviations list)

### Categorization Rules
- **Correct:** Proper definition + expansion present (or expansion not needed for context)
- **Missing Expansion:** Correct definition but no expansion in primary usage context
- **Error:** Wrong definition or contradictory usage

### Tools Used
- Python 3 script with regex pattern matching
- Reference definitions from `.claude/acronym-definitions.yaml`
- Context extraction with ±50 line window

---

## Files Generated

1. **`all-medications-analysis.json`**
   - Complete structured analysis
   - Machine-readable format for automation
   - Contains all 172 contexts with categorization

2. **`analyzer-v2.py`**
   - Analysis script with improved logic
   - Reusable for future verification
   - Extensible to additional acronyms

3. **`ANALYSIS_REPORT.md`** (this file)
   - Human-readable summary
   - Actionable recommendations
   - Methodology documentation

---

## Conclusion

**Overall Assessment: GOOD**

All medication acronyms use correct definitions. The 36 missing expansions are style/readability issues, not errors. The document is medically accurate regarding medication terminology.

**Next Steps:**
1. Review flagged locations and add expansions where appropriate
2. Consider chapter-level medication glossaries for dense chapters
3. Re-run analysis after corrections to verify completeness

**Analysis Complete:** 2026-01-31